Literature DB >> 26097569

Increased expression of metastasis-associated in colon cancer-1 in renal cell carcinoma is associated with poor prognosis.

Zhong Jin1, Naijin Xu2, Kai Guo1, Peng Xu1, Pengju Li1, Yiming Zhang1, Xiezhao Li1, Shaobo Zheng1, Chunxiao Liu1, Abai Xu1, Peng Huang1.   

Abstract

Metastasis-associated in colon cancer-1 (MACC1) expression in tumor specimens is an independent prognostic indicator of metastasis, which has recently gained considerable attention in cancer research, due to its overexpression in several types of carcinoma. However, MACC1 expression patterns and its possible role in renal cell carcinoma remain unknown. This study aimed to investigate MACC1 expression in renal cell carcinoma via immunohistochemical analysis and determine the relationship between MACC1 expression and cancer prognosis. Positive MACC1 expression was found to significantly correlate with distant metastasis and TNM stage (P < 0.05). A Kaplan-Meier survival analysis revealed that patients with higher MACC1 expression had a significantly lower disease-free rate (P < 0.05). These results indicate that MACC1 expression is significantly associated with prognosis in patients with renal cell carcinoma. To the best of our knowledge, this is the first study on the significance of MACC1 as a prognostic marker in renal cell carcinoma. MACC1 expression may be a useful target for the development of new therapeutic approaches, including molecular targeted therapeutic agents, for renal cell carcinoma.

Entities:  

Keywords:  MACC1; biomarker; prognosis; renal cell carcinoma

Mesh:

Substances:

Year:  2015        PMID: 26097569      PMCID: PMC4466956     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  16 in total

1.  Sorafenib in advanced clear-cell renal-cell carcinoma.

Authors:  Bernard Escudier; Tim Eisen; Walter M Stadler; Cezary Szczylik; Stéphane Oudard; Michael Siebels; Sylvie Negrier; Christine Chevreau; Ewa Solska; Apurva A Desai; Frédéric Rolland; Tomasz Demkow; Thomas E Hutson; Martin Gore; Scott Freeman; Brian Schwartz; Minghua Shan; Ronit Simantov; Ronald M Bukowski
Journal:  N Engl J Med       Date:  2007-01-11       Impact factor: 91.245

2.  Sunitinib versus interferon alfa in metastatic renal-cell carcinoma.

Authors:  Robert J Motzer; Thomas E Hutson; Piotr Tomczak; M Dror Michaelson; Ronald M Bukowski; Olivier Rixe; Stéphane Oudard; Sylvie Negrier; Cezary Szczylik; Sindy T Kim; Isan Chen; Paul W Bycott; Charles M Baum; Robert A Figlin
Journal:  N Engl J Med       Date:  2007-01-11       Impact factor: 91.245

3.  MACC1 as a marker for advanced colorectal carcinoma.

Authors:  Atsushi Shirahata; Kazuki Shinmura; Youhei Kitamura; Kazuma Sakuraba; Kazuaki Yokomizo; Tetsuhiro Goto; Hiroki Mizukami; Mitsuo Saito; Kazuyoshi Ishibashi; Gaku Kigawa; Hiroshi Nemoto; Kenji Hibi
Journal:  Anticancer Res       Date:  2010-07       Impact factor: 2.480

Review 4.  Colon cancer metastasis: MACC1 and Met as metastatic pacemakers.

Authors:  Franziska Arlt; Ulrike Stein
Journal:  Int J Biochem Cell Biol       Date:  2009-08-08       Impact factor: 5.085

5.  Potent antitumor effects of combined therapy with a telomerase-specific, replication-competent adenovirus (OBP-301) and IL-2 in a mouse model of renal cell carcinoma.

Authors:  P Huang; H Kaku; J Chen; Y Kashiwakura; T Saika; Y Nasu; Y Urata; T Fujiwara; M Watanabe; H Kumon
Journal:  Cancer Gene Ther       Date:  2010-02-19       Impact factor: 5.987

6.  Metastasis-associated in colon cancer-1 upregulation predicts a poor prognosis of gastric cancer, and promotes tumor cell proliferation and invasion.

Authors:  Lin Wang; Yajun Wu; Li Lin; Pengmin Liu; Hui Huang; Wenjun Liao; Dayong Zheng; Qiang Zuo; Li Sun; Na Huang; Min Shi; Yulin Liao; Wangjun Liao
Journal:  Int J Cancer       Date:  2013-03-29       Impact factor: 7.396

7.  MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis.

Authors:  Ulrike Stein; Wolfgang Walther; Franziska Arlt; Holger Schwabe; Janice Smith; Iduna Fichtner; Walter Birchmeier; Peter M Schlag
Journal:  Nat Med       Date:  2008-12-21       Impact factor: 53.440

8.  Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma.

Authors:  Gary Hudes; Michael Carducci; Piotr Tomczak; Janice Dutcher; Robert Figlin; Anil Kapoor; Elzbieta Staroslawska; Jeffrey Sosman; David McDermott; István Bodrogi; Zoran Kovacevic; Vladimir Lesovoy; Ingo G H Schmidt-Wolf; Olga Barbarash; Erhan Gokmen; Timothy O'Toole; Stephanie Lustgarten; Laurence Moore; Robert J Motzer
Journal:  N Engl J Med       Date:  2007-05-31       Impact factor: 91.245

9.  Molecular targeted therapy in advanced renal cell carcinoma: A review of its recent past and a glimpse into the near future.

Authors:  John S P Yuen
Journal:  Indian J Urol       Date:  2009 Oct-Dec

Review 10.  Adjuvant therapy in renal cell carcinoma-past, present, and future.

Authors:  Tobias Janowitz; Sarah J Welsh; Kamarul Zaki; Peter Mulders; Tim Eisen
Journal:  Semin Oncol       Date:  2013-08       Impact factor: 4.929

View more
  4 in total

1.  MicroRNA-877 is downregulated in cervical cancer and directly targets MACC1 to inhibit cell proliferation and invasion.

Authors:  Fanxu Meng; Jian Ou; Jinyu Liu; Xindi Li; Yanli Meng; Ling Yan; Ping Deng; Baosheng Sun
Journal:  Exp Ther Med       Date:  2019-09-09       Impact factor: 2.447

2.  Evaluation of gene expression level of CDC5L and MACC1 in poor prognosis and progression of osteosarcoma.

Authors:  Mohsen Mohammadi; Peyman Karimi Goudarzi; Omid Rahmani; Peyman Kaghazian; Emad Yahaghi; Afshin Taheriazam; Koroosh Ahmadi
Journal:  Tumour Biol       Date:  2015-12-29

3.  Construction of a 13-Gene Signature as a Novel Prognostic Marker for Patients with Clear Cell Renal Cell Carcinoma and the Role of XCR1 in Cell Proliferation.

Authors:  Baoying Yuan; Feifei Li; Youbao Li; Yuhan Chen
Journal:  Cancer Manag Res       Date:  2020-05-27       Impact factor: 3.989

4.  Metastasis-associated in colon cancer 1: A promising biomarker for the metastasis and prognosis of colorectal cancer.

Authors:  He Li; Yi-Xin Chen; Jia-Gen Wen; Hong-Hao Zhou
Journal:  Oncol Lett       Date:  2017-07-26       Impact factor: 2.967

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.